e-learning
resources
Vienna 2003
Monday 29.09.2003
Lung cancer: clinical and biological presentation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A comparison between 2 techniques (immunohistochemistry (IHC) and fluorescence in situ hybridisation (FISH)) for her-2/neu detection in lung cancer
A. P. Meert, B. Martin, J. M. Verdebout, V. Ninane, J. P. Sculier (Brussels, Belgium)
Source:
Annual Congress 2003 - Lung cancer: clinical and biological presentation
Session:
Lung cancer: clinical and biological presentation
Session type:
Poster Discussion
Number:
2284
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. P. Meert, B. Martin, J. M. Verdebout, V. Ninane, J. P. Sculier (Brussels, Belgium). A comparison between 2 techniques (immunohistochemistry (IHC) and fluorescence in situ hybridisation (FISH)) for her-2/neu detection in lung cancer. Eur Respir J 2003; 22: Suppl. 45, 2284
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
An immunohistochemistry (IHC) assessemnt of NSCLC cases
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008
Telomerase (h-TERT) and targeting EGFR in non small cell lung carcinoma: A combined immunohistochemistry and chromogenic in situ hybridization study based on tissue microarrays
Source: Annual Congress 2011 - Progress in pathology of lung cancer
Year: 2011
Usefulness of fluorescence in situ hybridization (FISH) as a molecular diagnostic approach in pleural effusions
Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions
Year: 2010
Evaluation of the
EGFR
gene expression in the malignant mesothelioma of Korea using fluorescence in situ hybridization
Source: Annual Congress 2008 - Inorganic dust exposure and the lung
Year: 2008
Differentiation between squamous cell carcinoma (SCC) and adenocarcinoma (AC): Expression of immunohistochemical (IHC) markers in a tissue microarray (TMA) of >1000 NSCLC
Source: Annual Congress 2011 - Molecular pathology and functional genomics of lung disease
Year: 2011
Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation
Source: Eur Respir J 2002; 20: 19S-23S
Year: 2002
Multiprobe FISH to enhance the detection of carcinoma cells in bronchial wash cytology
Source: Eur Respir J 2002; 20: Suppl. 38, 484s
Year: 2002
Prognosis related gene expression profile in early-stage squamous cell carcinoma of the lung (SqCLC) by real-time quantitative PCR (RT-QPCR)
Source: Annual Congress 2007 - Novel genetic markers in pathology
Year: 2007
RT-PCR and IHC as the alternative methods for detection of ALK aberrations in NSCLC samples - The feasibility study
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015
High-sensitive-detection of VEGF-mRNA in nonsmall-cell lung cancer (NSCLC) metastases of lymphnodes by thyramide amplified
in-situ
hybridization
Source: Eur Respir J 2001; 18: Suppl. 33, 233s
Year: 2001
Quantitative detection of ALK rearrangements using droplet digital PCR (ddPCR) in liquid biopsies of patients with non-small cell lung cancer (NSCLC)
Source: International Congress 2016 – New genomic targets in pulmonary disease
Year: 2016
Combined simultaneous analysis of the automated cyto-morphology and I-FISH on the same cell, as a novel method to detect a small population of lung cancer cells
Source: Eur Respir J 2006; 28: Suppl. 50, 335s
Year: 2006
Contribution of immunohistochemical (IHC) markers to the diagnosis of pulmonary carcinoids
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011
Real-time molecular imaging of EGFR mutations using fibred confocal fluorescence microscopy (FCFM)
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013
Immunohistochemical staining in detection and localization of mycobacterial tuberculosis in human histological samples (preliminary report)
Source: Eur Respir J 2007; 30: Suppl. 51, 196s
Year: 2007
Pathology of lung cancer: histology, cytology, immunohistochemistry and molecular pathology
Source: Eur Respir Mon; 2010: 48: 272–296
Year: 2010
Validation of PNA-LNA PCR clamp assay for detection of EGFR exon 19 and 21 mutations in various types of clinical non-small cell lung cancer specimens
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013
Prevalence of ALK translocations in a large cohort of non-small cell cancer patients and quality of hybridization by sampling method.
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017
Quantitative RT-PCR 3-gene expression signature predicts survival in early-stage non-small cell lung cancer (NSCLC) patients (pts)
Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Year: 2008
An analysis of mRNA and long non-coding RNA (lncRNA) expression during the progression from pre-invasive lesions (PL) to invasive squamous cell carcinoma (SqCC) of the bronchus
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept